282 related articles for article (PubMed ID: 27212611)
1. [Predictive and prognostic factors of preeclampsia: Interest of PlGF and sFLT-1].
Vieillefosse S; Guibourdenche J; Atallah A; Haddad B; Fournier T; Tsatsaris V; Lecarpentier E
J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):999-1008. PubMed ID: 27212611
[TBL] [Abstract][Full Text] [Related]
2. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia.
Lecarpentier É; Vieillefosse S; Haddad B; Fournier T; Leguy MC; Guibourdenche J; Tsatsaris V
Ann Biol Clin (Paris); 2016 Jun; 74(3):259-67. PubMed ID: 27237799
[TBL] [Abstract][Full Text] [Related]
3. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
[TBL] [Abstract][Full Text] [Related]
4. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
[TBL] [Abstract][Full Text] [Related]
5. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis].
Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M
Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314
[TBL] [Abstract][Full Text] [Related]
6. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
7. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
8. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
9. [Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia].
Bubeníková Š; Cíchová A; Roubalová L; Durdová V; Vlk R
Ceska Gynekol; 2016; 81(4):272-278. PubMed ID: 27882748
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
[TBL] [Abstract][Full Text] [Related]
12. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
13. The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.
Govender N; Moodley J; Naicker T
Afr J Reprod Health; 2018 Dec; 22(4):135-143. PubMed ID: 30632730
[TBL] [Abstract][Full Text] [Related]
14. Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.
Costa RA; Hoshida MS; Alves EA; Zugaib M; Francisco RP
Hypertens Pregnancy; 2016 May; 35(2):139-49. PubMed ID: 26930132
[TBL] [Abstract][Full Text] [Related]
15. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
Schlembach D; Hund M; Schroer A; Wolf C
BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
[TBL] [Abstract][Full Text] [Related]
16. [What place for the biomarkers of preeclampsia?].
Tsatsaris V
Gynecol Obstet Fertil Senol; 2017; 45(7-8):385-386. PubMed ID: 28784350
[No Abstract] [Full Text] [Related]
17. sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics.
Tarasevičienė V; Grybauskienė R; Mačiulevičienė R
Medicina (Kaunas); 2016; 52(6):349-353. PubMed ID: 27940029
[TBL] [Abstract][Full Text] [Related]
18. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia.
Álvarez-Fernández I; Prieto B; Rodríguez V; Ruano Y; Escudero AI; Álvarez FV
Clin Chim Acta; 2016 Dec; 463():150-157. PubMed ID: 27983995
[TBL] [Abstract][Full Text] [Related]
20. First and Second Trimester Serum sFlt-1/PlGF Ratio and Subsequent Preeclampsia: A Systematic Review.
Yusuf AM; Kahane A; Ray JG
J Obstet Gynaecol Can; 2018 May; 40(5):618-626. PubMed ID: 28927814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
